When most people hear about CAR-T cell therapy, they think of cancer treatment. However, a recent study has revealed a new surprising possibility - repairing damaged tissue in patients with systemic sclerosis which is a rare autoimmune disease that causes hardening and scarring of the skin and internal organs.
Researchers examined patients with systemic sclerosis who received CD19-CAR T cell therapy and discovered signs of remarkable skin remodeling. The treatment showed signs of restoring some normal skin structures which was initially aimed at slowing the disease progression. Scientists observed recovery of skin papillae; tiny structures that help maintain healthy skin as well as signs of blood vessel repair and normalization of fibroblasts, the cells responsible for producing connective tissue.
What makes this finding exciting is that fibrosis or tissue scarring, has been considered difficult to reverse. Current treatments mainly focus on managing symptoms and preventing further damage. This research suggests that advanced immune therapies may one day help regenerate tissues that were once thought to be permanently damaged.
While more studies are needed, these findings offer hope that the future of medicine has higher potentials to make impossible into possible.
Read this research article for details : Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells | Nature Communications Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells | Nature Communications
If cells can be engineered to repair damaged tissues, what other possibilities might biotechnology unlock?
MBH/PS